Second vaccine shipment arrives
The Joint Information Center today reported Guam's 123rd Covid-19-related fatality, which occurred at the Guam Memorial Hospital (GMH) at approximately 11:50 a.m. The patient was a 68-year-old male with underlying conditions. He was admitted to GMH on December 14, 2020 and was a known positive.
“Nothing can truly prepare us for the loss of a loved one, and COVID-19 is especially ruthless in its isolation. We are told by scripture that those who mourn shall be comforted, and I hope you do find comfort in the support and love of those around you. Jeff, Lt. Governor Josh, and I send his family and friends our heartfelt condolences and sympathies," said Gov. Lou Leon Guerrero.
Zero new cases of COVID-19 were identified out of 34 tests performed on Friday, January 1, 2021.
To date, there have been a total of 7,326 officially reported cases of COVID-19 with 123 deaths, 156 cases in active isolation and 7,047 not in active isolation. The number of hospitalization is down to 13, with three in ICU and two on ventilator.
The Department of Public Health and Social Services (DPHSS) received its second shipment of Moderna vaccines early Saturday morning. The latest shipment consisted of 6,300 doses, bringing Guam’s total of Moderna vaccine doses to 7,600. This supply will fully immunize 3,800 individuals.
DPHSS, in collaboration with the Guam Community College (GCC), Mayors’ Council of Guam, Guam National Guard, Department of Public Works, Guam Police Department, Guam Fire Department, University of Guam School of Nursing and Health Sciences, and other Government of Guam and Federal Agencies, will resume COVID-19 community testing on Jan. 4 and 5 at GCC from 8 a.m. to 12 p.m. The first hour on both days, from 8 a.m. to 9 a.m., will be reserved for GCC students, faculty and staff only.
DPHSS will offer up to 300 tests per day on a first-come, first-served basis.
For the safety of the community and the nurses, only four people per vehicle are allowed to be tested. No symptoms are needed to qualify for testing.